Editor-in-Chief

Prof. Baofeng Yang, Academician of Chinese Academy of Engineering, doctoral supervisor, honorary professor of world-famous universities in the US, Russia, Australia and Japan. Professor Yang is Director of state key pharmacology discipline, Chief scientist of “973” program project, Vice chairman of Science & Technology Society of Heilongjiang Province, Honorary Chairman of Chinese Cardiovascular Pharmacologic Society, Scientific committee member of China’s Education Ministry.

Prof. Baofeng Yang evaluated the effects of over 50 drugs on the cardiovascular system and proposed the theory “Best Target of Antiarrhythmic Drug Action”, which was indited into the book—Ion Channel Pharmacology; Prof. Baofeng Yang developed a few therapeutic drugs such as Nianlianping and Daming capsule, which have been used in clinic and brought great economic benefits. Prof. Baofeng Yang has published over 300 SCI-indexed papers in prestigious academic journals. Prof. Baofeng Yang was the editor-in-chief of the medical textbook——Pharmacology (Sixth, Seventh, Eighth, and Ninth Edition), which was rewarded as the First Prize of National Pharmaceutical Excellent Teaching Material. In the past years, Prof. Baofeng Yang was awarded some prizes, which includes: The Second Prize of the State Natural Science Award of Science and Technology Progress in 2004, National Teaching Master in 2011.

 

Co-Editor-in-Chief

Stanley Nattel

Prof. Stanley Nattel, Editor-in-Chief of Canadian Journal of Cardiology, Professor in Montreal Heart Institute, is a world-renowned cardiologist with deep expertise in cardiac ion channels, atrial fibrillation and new drug target research.